Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide as Add-on Therapy in Parkinson's Disease with Motor Fluctuations
NCT01187966Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Jan 2007
- Primary completion
- Oct 2008
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Jan 2007; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01187966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187966.